Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model
Qian Shi, Cheng Chang, Afaf Saliba, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 27, pp. 5294-5313
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Molecular and metabolic heterogeneity of astrocytes and microglia
Philip Hasel, William H. Aisenberg, F. Chris Bennett, et al.
Cell Metabolism (2023) Vol. 35, Iss. 4, pp. 555-570
Open Access | Times Cited: 54
TREM2: Potential therapeutic targeting of microglia for Alzheimer's disease
Yueran Li, Huifang Xu, Huifang Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115218-115218
Open Access | Times Cited: 47
Rapamycin and Alzheimer disease: a hypothesis for the effective use of rapamycin for treatment of neurodegenerative disease
Julian M. Carosi, Timothy J. Sargeant
Autophagy (2023) Vol. 19, Iss. 8, pp. 2386-2390
Open Access | Times Cited: 23
Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging
Seokjo Kang, Emily Y. Ko, Amelia E. Andrews, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Microglia, Trem2, and Neurodegeneration
Qian Shi, Raul A. Gutierrez, Manzoor A. Bhat
The Neuroscientist (2024)
Open Access | Times Cited: 10
Genomic and Transcriptomic Approaches Advance the Diagnosis and Prognosis of Neurodegenerative Diseases
Zheng Liu, Siyuan Song
Genes (2025) Vol. 16, Iss. 2, pp. 135-135
Open Access | Times Cited: 1
Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research
Eun Sun Jung, Hayoung Choi, Inhee Mook‐Jung
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine
Jacqueline Silva, Giulio Taglialatela, Daniel C. Jupiter
Journal of Alzheimer s Disease (2023) Vol. 95, Iss. 2, pp. 585-597
Open Access | Times Cited: 22
DHCR24 reverses Alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xFAD mice
Wenbin Zhang, Yue Huang, Xiaorou Guo, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 21
Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
Izabela Lepiarz‐Raba, Ismail Temitayo Gbadamosi, Roberta Florea, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 21
A pharmacological toolkit for human microglia identifies Topoisomerase I inhibitors as immunomodulators for Alzheimer’s disease
Verena Haage, John F. Tuddenham, Natacha Comandante-Lou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 8
Mitophagy activation by rapamycin enhances mitochondrial function and cognition in 5×FAD mice
Wenrong Zheng, Kualiang Li, Meihua Zhong, et al.
Behavioural Brain Research (2024) Vol. 463, pp. 114889-114889
Open Access | Times Cited: 7
Psilocybin for the treatment of Alzheimer’s disease
Siyi Zheng, Rong Ma, Yang Yang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 7
An integrated approach to identifying sex-specific genes, transcription factors, and pathways relevant to Alzheimer's disease
Adolfo López‐Cerdán, Zoraida Andreu, Marta R. Hidalgo, et al.
Neurobiology of Disease (2024) Vol. 199, pp. 106605-106605
Open Access | Times Cited: 6
Metformin and Trehalose-Modulated Autophagy Exerts a Neurotherapeutic Effect on Parkinsonʼs Disease
Yareth Gopar-Cuevas, Odila Saucedo‐Cárdenas, María de Jesús Loera‐Arias, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 12, pp. 7253-7273
Closed Access | Times Cited: 16
mTOR signaling and Alzheimer's disease: What we know and where we are?
Samin Davoody, Afsaneh Asgari Taei, Pariya Khodabakhsh, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 16
Rapamycin Responds to Alzheimer’s Disease: A Potential Translational Therapy
Si-Jia Hou, Sheng‐Xiao Zhang, Li Yang, et al.
Clinical Interventions in Aging (2023) Vol. Volume 18, pp. 1629-1639
Open Access | Times Cited: 15
Pharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives
Pei-Lun Xie, Meng-Yu Zheng, Ran Han, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Common cytokine receptor gamma chain family cytokines activate MAPK, PI3K, and JAK/STAT pathways in microglia to influence Alzheimer’s Disease
Hannah Zuppe, Erin G. Reed-Geaghan
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 5
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases
Yuchen He, Yishu Fan, Xenab Ahmadpoor, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2472-2509
Closed Access | Times Cited: 4
Senescent microglia: The hidden culprits accelerating Alzheimer’s disease
Li Wu, Xie Yong-Yan, Mu Jia-Xin, et al.
Brain Research (2025), pp. 149480-149480
Closed Access
Docking and Molecular Dynamic Simulation of ApoE isoforms to Trem2
Steven Lehrer, Peter H. Rheinstein
Research Square (Research Square) (2025)
Closed Access
Ketamine does not rescue plaque load or gap detection in the 5XFAD mouse model of Alzheimer's disease
Anne L. Wright, Aldis P. Weible, Olivia B. Estes, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Glucose Metabolic Reprogramming in Microglia: Implications for Neurodegenerative Diseases and Targeted Therapy
Mengqi Fang, Yuan Zhou, Keren He, et al.
Molecular Neurobiology (2025)
Closed Access
Antibody Immunotherapies for Personalized Opioid Addiction Treatment
Eric H. Rosenn, Miriam Korlansky, Shahin Benyaminpour, et al.
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 4, pp. 103522-103522
Closed Access
Page 1 - Next Page

Scroll to top